Biotech Values

[DewDiligence]

AGN MRX: …black box for all botulinum-toxin products

AGN’s Pyott thinks the class black-box warning for botulinum toxins will increase Botox’s market share in the US by making injectors less likely to switch from tried–and-true Botox to the unknown Dysport. He may have a point.

From a medical standpoint, the FDA’s black-box warning for all drugs in this class is much ado about nothing, IMO. These products are extremely safe when administered by experienced injectors.